15 September 2026 · The Pharmacist
Trial links specialist NHS long Covid care to reduced fatigue
Findings from a major clinical trial indicate that around six in ten patients experienced a clinically meaningful improvement in fatigue after completing 12 weeks of care within specialist NHS long Covid clinics. The research, conducted under the Stimulate-ICP trial, evaluated outcomes across six dedicated NHS clinics in England and included more than 1,100 participants, making it the largest clinical trial of long Covid care to date.
The trial evaluated the impact of specialist NHS services established to support individuals with persistent symptoms following coronavirus infection. Fatigue remains one of the primary symptoms reported by patients seeking care for post-acute illness, and the trial data provides structured evidence regarding symptom management and recovery trajectories under dedicated clinical oversight over a three-month timeframe.
While complete granular data across the study sites remains limited in initial reporting, the trial establishes an evidence base for formal long Covid clinical pathways. For primary and secondary healthcare providers, these findings offer insight into expected recovery timelines and the clinical utility of specialised post-viral care models.
For UK online pharmacies and digital health brands, these findings suggest that maintaining clear triage and referral pathways into specialist NHS services may be beneficial when advising patients who report persistent post-viral fatigue.